drugset / Trial / NCT07224490
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Phase 1
Recruiting
40 enrolled
Massachusetts General Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
NaSingle-groupOpen-labelOther
Summary
The objective of this protocol is to use a case-control paradigm to compare the response to an intravenous administration of kisspeptin in individuals with and without post-covid-19 syndrome. The study subjects will receive a single bolus of kisspeptin.
Timeline
- Start
- 2026-03-10
- Primary completion
- 2030-05
- Completion
- 2030-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | kisspeptin 112-121 | Peptide | 0.313 ug/kg | Intravenous |
| Subject | kisspeptin 112-121 | Peptide | 13.19 ug/kg | Intravenous |